Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.

CSE:AGN - Post by User

Algernon Pharmaceuticals Inc.

Bullboard Posts

Comment by grosdavidon Apr 22, 2020 10:17am

67 Views

Post# 30938602

RE:RE:RE:RE:RE:RE:Today is going to be a great day for our AGN!!

Look man, I find completely absurd to be here and just bash with nothing to support. You know you don't have to be here, sorry if you sold too soon.

Go have fun with your others stocks. AGN is rock solid right now, no doubt it will achieve something bigger than you have ever thought.

We have exclusivity regarding NP-120, come back and check on us in two weeks time.

David

Bullboard Posts

Gold vs. bitcoin, where should you invest?